Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07171684 · ClinicalTrials.gov registry record · NA
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
A NA study of Gestational Diabetes and Diabetes in Pregnancy, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 176
- Enrollment target
- 1
- Study location
NCT07171684 is a NA study of Gestational Diabetes and Diabetes in Pregnancy that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 176 participants, below the 318-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07171684, a NA study of Gestational Diabetes and Diabetes in Pregnancy, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to see if diabetes in pregnancy can be treated with once daily dosing of insulin instead of once daily dosing plus insulin with meals. The main question this study aims to answer is: 1. Can a once daily dose of long-acting insulin control blood sugars as well as long-acting insulin plus meal-time insulin? 2. Do babies born to mothers who take one dose of long-acting insulin have more complications after birth than babies born to mothers who take long-acting and meal-time insulin? Researchers will compare one dose of long-acting insulin per day to this plus three doses of short-acting insulin with each meal to see if blood sugars are controlled. Participants will send their blood sugar logs to the study staff weekly, instead of to their OB/GYN, for adjustments to their insulin dosing.
Conditions Studied
Interventions
- DRUG Insulin glargine alone
- DRUG Insulin glargine + insulin lispro
Study Locations (1)
New Jersey
- Robert Wood Johnson Univeristy Hospital - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2025-11-26 |
| Est. Completion | 2027-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07171684
The ClinicalTrials.gov registry entry for NCT07171684 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 318-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (45% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gestational Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Insulin glargine alone is the first listed.
NCT07171684 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07171684 about?
NCT07171684 is a clinical study titled "Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)". The goal of this clinical trial is to see if diabetes in pregnancy can be treated with once daily dosing of insulin instead of once daily dosing plus insulin with meals. The main question this study aims to answer is: 1. Can a once daily dose of long-acting insulin control blood sugars as well as l...
What is the current status of trial NCT07171684?
This trial is currently recruiting. It is a NA study. The enrollment target is 176 participants. The study started on 2025-11-26. Estimated completion is 2027-05-15.
What conditions does trial NCT07171684 study?
This clinical trial studies the following conditions: Gestational Diabetes, Diabetes in Pregnancy.
What interventions are being tested in trial NCT07171684?
The interventions under investigation include: Insulin glargine alone (DRUG), Insulin glargine + insulin lispro (DRUG).
Who is sponsoring clinical trial NCT07171684?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07171684 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.